Key takeaways:
Mavyret (glecaprevir/pibrentasvir) is a combination medication used to treat hepatitis C.
Mavyret is usually well-tolerated, but it still has a number of possible side effects. They include headache, feeling tired, nausea, and others.
There are things you can do to manage the possible side effects of Mavyret, such as incorporating certain diet and lifestyle changes when needed.
Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Hepatitis C causes liver inflammation (swelling). If left untreated, it can lead to complications like cirrhosis and liver cancer. Although some people clear the infection on their own, more than 50% of people develop a chronic infection.
If you live with chronic hepatitis C, there's a chance you may have heard of Mavyret (glecaprevir/pibrentasvir). Mavyret is a combination medication containing two medications inside a single tablet or pellet. It's used to treat chronic hepatitis C in people ages 3 and older.
When taken as prescribed, it's an effective treatment option that’s often well-tolerated. However, like all medications, it has a number of possible risks and side effects. Thankfully, there are ways to manage these side effects. Knowing what to expect — and how to take action — can help make sure you’re able to take this helpful hepatitis C medication.
Here, we'll learn more about Mavyret and what you can expect if you’re prescribed this medication.
Mavyret is a prescription medication that is taken by mouth. It's a combination of two direct-acting antiviral (DAA) medications that help the immune system clear HCV.
It's available in two forms — tablets or pellets. It's FDA-approved to treat all major genotypes of chronic hepatitis C without cirrhosis (liver scarring) or with compensated cirrhosis.
Genotypes are like different strains of HCV. Compensated cirrhosis is an early stage of liver failure where you don’t have symptoms, and the liver is still functioning relatively well.
Mavyret is also FDA-approved to treat people with HCV genotype 1 infection who had prior therapy that worked the same way as either medication in Mavyret, but not both. This is discussed more below.
And, even though it treats chronic hepatitis C, you usually only take Mavyret for a few weeks. Treatment courses are usually only 8 to 16 weeks (about 2 to 4 months) depending on your situation. Other treatments you may have used previously also play a role in your treatment length.
As mentioned, Mavyret contains two medications — glecaprevir and pibrentasvir.
Glecaprevir is an HCV NS3/4A protease inhibitor. This means it works by blocking an enzyme needed to cut proteins that allow HCV to replicate. Pibrentasvir is an HCV NS5A inhibitor. NS5A is a protein needed for HCV replication and assembly.
By blocking both NS3/4A protease and NS5A, Mavyret reduces the amount of HCV in your body to undetectable levels. It does this by preventing HCV replication with a goal of curing HCV infection.
Mavyret is generally well-tolerated. Many people are able to take it without experiencing bothersome side effects. However, side effects are still possible. The most common short-term side effects associated with Mavyret are:
Headache
There are a couple of long-term and potentially serious side effects to be aware of.
Mavyret has a boxed warning — the most serious type of warning the FDA can give a medication — for hepatitis B concerns.
More specifically, if you have hepatitis C and are receiving Mavyret, it may cause hepatitis B virus (HBV) reactivation during or after Mavyret therapy. This is when HBV becomes active in the body again if you’ve had a HBV infection in the past. HBV reactivation in some people has caused fulminant hepatitis (sudden liver failure), liver failure, and death. Because of this, your care team will likely run tests for HBV infection before potentially giving you Mavyret.
For other people who take Mavyret, serious liver problems, such as liver failure and death, are rare but possible. This risk is higher for people who had advanced liver problems before starting Mavyret. To lower these risks, your healthcare provider will regularly check your labs and watch for signs of liver problems.
The following side effects are serious and should be reported to your healthcare provider immediately:
Yellow eyes or skin
Pain in the upper-right area of your stomach or swelling of the stomach
Intense nausea or vomiting
Feeling tired
Confusion
Bruising more easily
Dark-colored urine or stool
Immediate medical attention is often necessary for the symptoms above. But if you have any of the following symptoms, it’s recommended to seek emergency treatment:
Allergic reactions (e.g., skin rash, itching, hives)
Swelling of face, lips, or tongue
Trouble breathing
While you're taking Mavyret, your healthcare provider will run routine tests (like liver function tests) to make sure your body is tolerating it. But if you experience — or think you're experiencing — any of these side effects, reach out to your healthcare provider immediately.
At this time, it's not known if Mavyret is safe for pregnant or nursing women. If you're pregnant or nursing and are interested in Mavyret, talk to your healthcare provider for specific guidance.
It's important to complete your full course of Mavyret to make sure you clear HCV from your body. Having a good support system before starting therapy — with friends, family, and your healthcare provider — can help you manage side effects and have a better experience.
Your pharmacist and healthcare provider can provide you with specific guidance on how to successfully receive Mavyret. But the following tips may help you manage some of the more common side effects:
Headache
Try to stay hydrated throughout the day. Many well-hydrated people often drink about 90 to 120 oz of water daily, although it can vary from person to person
Try to get plenty of rest when possible.
Ask your healthcare provider if it is safe for you to take acetaminophen (Tylenol).
Fatigue
Ask your healthcare provider if you’re healthy enough to try low-intensity exercise (e.g., walking, swimming, stationary cycling).
Try to stay hydrated.
Get some rest during the day.
Reduce your work schedule, if possible.
Eat well-balanced meals.
Nausea
Eat several small meals every day.
Eat foods that are chilled and avoid foods with strong smells.
Try ginger (e.g., ginger candies, ginger ale, or ginger tea).
Eat bland foods, such as dry toast or crackers.
Your healthcare provider may recommend over-the-counter (OTC) medications or certain medications — called antiemetics — to prevent or treat nausea.
Diarrhea
Eat soft foods that are low in fiber. Bananas, rice, and white toast (BRAT diet) aren’t likely to upset your stomach.
Avoid spicy or acidic foods (e.g., citrus fruits, tomato sauce).
Avoid dairy products for 2 to 3 days after diarrhea stops.
Your healthcare provider may recommend OTC medications, like loperamide (Imodium), to help treat diarrhea.
Mavyret is a combination medication that contains two medications inside of a single tablet or pellet. It's used to treat hepatitis C. But it has a number of side effects, some of which could be serious. Remember to let your healthcare provider know about any bothersome side effects you experience while taking it. That way, they can give you tips for how to manage them.
If you're curious if Mavyret is an option for you, talk to your healthcare provider for more information.
AbbVie. (2021). Mavyret [package insert].
AbbVie. (2021). Mavyret [patient information sheet].
Centers for Disease Control and Prevention. (2020). Hepatitis C.
Centers for Disease Control and Prevention. (2020). Hepatitis C questions and answers for the public.
Centers for Disease Control and Prevention. (2020). What is viral hepatitis?
Dustin, L. B., et al. (2016). Hepatitis C virus: Life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy. Clinical Microbiology and Infection.
Ichai, P., et al. (2019). Management of fulminant hepatitis B. Current Infectious Disease Reports.
National Center for Biotechnology Information. (2022). PubChem compound summary for glecaprevir.
National Center for Biotechnology Information. (2022). PubChem compound summary for pibrentasvir.
Nemeth, V., et al. (2021). Diarrhea. StatPearls.
U.S. Department of Veterans Affairs. (2018). Genotypes hepatitis C.
U.S. Department of Veterans Affairs. (2019). Classification of direct-acting antiviral agents in HCV treatment regimens.
U.S. Department of Veterans Affairs. (2019). Stages of cirrhosis.
Veterans Health Administration. (2017). Managing side effects of Mavyret. U.S. Department of Veterans Affairs.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.